Neurofeedback to improve neurocognitive functioning of children treated for a brain tumor: design of a randomized controlled double-blind trial

BACKGROUND: Neurotoxicity caused by treatment for a brain tumor is a major cause of neurocognitive decline in survivors. Studies have shown that neurofeedback may enhance neurocognitive functioning. This paper describes the protocol of the PRISMA study, a randomized controlled trial to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: de Ruiter, Marieke A, Meeteren, Antoinette YN Schouten-Van, van Mourik, Rosa, Janssen, Tieme WP, Greidanus, Juliette EM, Oosterlaan, Jaap, Grootenhuis, Martha A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530427/
https://www.ncbi.nlm.nih.gov/pubmed/23217162
http://dx.doi.org/10.1186/1471-2407-12-581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530427/
https://www.ncbi.nlm.nih.gov/pubmed/23217162
http://dx.doi.org/10.1186/1471-2407-12-581

Ejemplares similares